SM
KITE

Sabby Management’s Kite Pharma, Inc. KITE Stock Holding History

Sabby Management’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,171
Closed -$5.25M – 363
2016
Q4 		$5.25M Buy
1,171
+89
+8% +$4.37K 0.31% 48
2016
Q3 		$6.04M Buy
1,082
+231
+27% +$12.9K 0.23% 67
2016
Q2 		$4.25M Buy
851
+246
+41% +$12.1K 0.22% 60
2016
Q1 		$1.63M Buy
+605
New +$29.3K 0.08% 121

Sabby Management's KITE Position: Q3 2017 in Review

Sabby Management sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 31,384 shares — an estimated $4.37M sold.

Sabby Management first reported a position in KITE in Q2 2015 and held it in 4 quarters. The position peaked at $7.63M in Q3 2015. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

  • Sabby Management reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
  • Sabby Management sold 31,384 Kite Pharma, Inc. shares in Q3 2017, an estimated $4.37M.
  • Sabby Management first reported a position in Kite Pharma, Inc. in Q2 2015 and held it in 4 quarters.
  • Sabby Management's Kite Pharma, Inc. position peaked at $7.63M in Q3 2015.
  • 244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on Sabby Management's 13F filing for Q3 2017, filed 14 Nov 2017.